© Rosalind Scientific LLC 2018-2022
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >4,000 drug hunters worldwide, unsubscribe anytime.
Home > OI338
<< Back to December
oral, ultralong-acting insulin analog
effective in Ph. IIa, hum. t1/2~3 d, 4% F dog
albumin-binding motif + reduced endocytosis
J. Med. Chem., Dec. 28, 2020
Novo Nordisk, Maaloev, DK
Novo oral insulin analog
Unlock this content with a Premium membership to read it now.